Patient Guide: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abiraterone Acetate and Prednisone (AA-P) Versus Placebo Combined With AA-P as First-Line Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 147 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04691804
Status: ACTIVE_NOT_RECRUITING
Condition: Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Phase: PHASE3

Find a Study Location Near You

This study is available at 147 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Anchorage, Alaska
  • Tucson, Arizona
  • Rancho Mirage, California
  • • And 144 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily